Figure 1.
Schematic representation of Red Blood Cells (RBCs) generation from induced pluripotent stem cells (iPS). Fibroblasts are isolated from the skin of the patient and reprogrammed in vitro into iPS. iPS can be differentiated in vitro in RBCs and be used for blood transfusion. Patient-specific iPS can be powerful tools for disease modelling or drug discovery processes.